Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
RemeGen H, headquartered in China, is a leading biopharmaceutical company specializing in the research, development, and commercialization of innovative biologics. The company focuses on advancing novel therapies to address unmet medical needs in autoimmune diseases, oncology, and ophthalmology worldwide.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
RemeGen H is scheduled to report its next quarterly earnings on 11/04/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
RemeGen H last reported quarterly earnings on 8/24/2026 (Q2 2026).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.